Biofrontera Inc. to Participate in the Lytham Partners Spring 2026 Investor Conference on May 28, 2026

Biofrontera (Nasdaq:BFRI), a biopharmaceutical company focused on photodynamic therapy, will participate in the Lytham Partners Spring 2026 Investor Conference on May 28, 2026.

Rhea-AI Summary

Biofrontera (Nasdaq:BFRI), a biopharmaceutical company focused on photodynamic therapy, will participate in the Lytham Partners Spring 2026 Investor Conference on May 28, 2026.

Management will deliver a webcast at 11:00 a.m. ET and hold virtual one-on-one investor meetings, with the webcast available for replay.

Argus May 21 session

-3.42% close to close Open Argus

Details

News Market Reaction – BFRI

In the May 21 session, BFRI declined 3.42%, reflecting a moderate negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

Market Context

This announcement outlines Biofrontera’s participation in a virtual investor conference on May 28, 2...

Analysis

This announcement outlines Biofrontera’s participation in a virtual investor conference on May 28, 2026, including a webcast at 11:00 a.m. ET and one‑on‑one investor meetings. It follows recent updates on revenue growth, margin expansion, and an upcoming PDUFA date in September 2026. Investors may watch how management’s messaging at this event builds on prior earnings results and clinical and regulatory milestones disclosed earlier in 2026.

Key Figures

Conference date: May 28, 2026 Webcast time: 11:00 a.m. ET

Conference date

May 28, 2026

Lytham Partners Spring 2026 Investor Conference

Webcast time

11:00 a.m. ET

Company webcast presentation during conference

Historical Context

5 past events · Latest: May 14

5 events

1. May 14

   Q1 2026 earnings

   24h Move

   +3.0%

   Reported Q1 growth, margin expansion, positive trials and FDA sNDA progress.

2. May 13

   Awareness campaign

   24h Move

   -5.0%

   Launched #HatsOnForAK campaign to promote actinic keratosis awareness.

3. May 08

   Earnings call date

   24h Move

   -3.5%

   Announced timing and access details for Q1 2026 results call.

4. Mar 19

   FY 2025 earnings

   24h Move

   -1.5%

   Reported record Q4 and full‑year 2025 revenue and strong margin gains.

5. Mar 09

   Earnings call date

   24h Move

   +0.7%

   Set date and time for Q4 and FY 2025 results and webcast.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Key Terms

photodynamic therapy (pdt)

1 terms

photodynamic therapy (pdt) medical

"a biopharmaceutical company specializing in the development and commercialization of photodynamic therapy (PDT)"

Photodynamic therapy (PDT) is a medical treatment that uses special light-sensitive drugs and a light source to target and destroy abnormal or cancerous cells. It works like a precise spotlight, activating the drug only in the affected area to minimize damage to surrounding tissue. While primarily a health care method, its development and adoption can influence biotech and pharmaceutical markets, making it relevant for investors tracking advancements in medical technology.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

WOBURN, Mass., May 21, 2026 (GLOBE NEWSWIRE) -- Biofrontera Inc. (Nasdaq: BFRI) (“Biofrontera” or the “Company”), a biopharmaceutical company specializing in the development and commercialization of photodynamic therapy (PDT), will participate in a webcast presentation and host one-on-one meetings with investors at the Lytham Partners Spring 2026 Investor Conference, taking place virtually on Thursday, May 28, 2026.

Company Webcast

The webcast presentation will take place at 11:00 a.m. ET on Thursday, May 28, 2026. The webcast can be accessed by visiting the conference home page at https://lythampartners.com/spring2026/ or directly at https://app.webinar.net/xrp2JnwZa5Y. The webcast will also be available for replay following the event.

1x1 Meetings

Management will be participating in virtual one-on-one meetings throughout the event. To arrange a meeting with management, please contact Lytham Partners at 1x1@lythampartners.com or register for the event at https://lythampartners.com/spring2026invreg/.

About Biofrontera Inc.

Biofrontera is a U.S.-based biopharmaceutical company specializing in the treatment of dermatological conditions with a focus on PDT. The Company commercializes the drug-device combination Ameluz^® with the RhodoLED^® lamp series for PDT of Actinic Keratosis, pre-cancerous skin lesions which may progress to invasive skin cancers¹. The Company performs clinical trials to extend the use of the products to treat non-melanoma skin cancers and moderate-to-severe acne. For more information, visit www.biofrontera-us.com and follow Biofrontera on LinkedIn and X.

Investor Relations

Ben Shamsian
646-829-9701
shamsian@lythampartners.com

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When is Biofrontera (BFRI) presenting at the Lytham Partners Spring 2026 Investor Conference?

Biofrontera will present at the Lytham Partners Spring 2026 Investor Conference on Thursday, May 28, 2026 at 11:00 a.m. ET. The event is virtual, allowing investors to attend online from any location.

How can investors watch the Biofrontera (BFRI) webcast on May 28, 2026?

Investors can access Biofrontera’s webcast by visiting the conference home page at lythampartners.com/spring2026 or directly via the provided webinar link. According to the company, a replay will be available following the live event.

Will the Biofrontera (BFRI) Lytham Partners conference presentation be available for replay?

Yes, the Biofrontera webcast from the Lytham Partners Spring 2026 Investor Conference will be available for replay after the event. According to the company, investors can revisit the presentation through the same webcast access links.

How can investors schedule one-on-one meetings with Biofrontera (BFRI) at the Spring 2026 Lytham conference?

Investors can arrange virtual one-on-one meetings with Biofrontera’s management by contacting Lytham Partners at 1x1@lythampartners.com or registering at the conference page. According to the company, management will participate in such meetings throughout the event.

What type of company is Biofrontera (BFRI) participating in the Lytham Partners Spring 2026 Investor Conference?

Biofrontera is described as a biopharmaceutical company specializing in photodynamic therapy (PDT). Its participation in the Lytham Partners Spring 2026 Investor Conference offers investors a chance to learn more about its PDT-focused development and commercialization activities.